CSTL vs HCA · rev $187.2M vs P/E 17, rev $75.60B
Castle Biosciences Inc (CSTL) versus HCA Holdings Inc (HCA) — a side-by-side from cached financials, not a winner call.
Castle Biosciences Inc (CSTL) is a diagnostics & research company listed on US.
HCA Holdings Inc (HCA) is a medical care facilities company listed on US.
Latest reported CSTL revenue for 2026-06-30 was $187.2M. Net income was -$16.6M. CSTL currently screens at market cap $570.2M.
Latest reported HCA revenue for 2025-12-31 was $75.60B. Net income was $6.78B. Revenue was up 7.1% from 2024-12-31 to 2025-12-31. HCA currently screens at market cap $91.01B and trailing P/E 16.8.
CSTL currently screens at market cap $570.2M. HCA currently screens at market cap $91.01B and trailing P/E 16.8.
Not investment advice. Open the CSTL and HCA stock pages for the full models.
Not investment advice.